Kannur varsity researchers get US patent

Share this:

A analysis crew of the division of biotechnology and microbiology at Kannur University, comprising Prof. A. Sabu, M. Haridas, and Prasanth Shankar, has been awarded a US patent for the invention of ‘Phormidin’ an inhibitor of the enzyme Fatty Acid Synthase (FAS).

This is the primary worldwide patent earned by the college. The award gives the promise of growing a brand new drug for most cancers remedy.

The patent comes as a end result of virtually 10 years of analysis that started in 2010 with assist from the Ministry of Earth Sciences.

According to Prof. Sabu, FAS inhibitors are anticipated to be future medicine in most cancers remedy. FAS is crucial for fats metabolism, and its inhibition results in the dying of the cell.

Phormidin has nice potential within the remedy of weight problems, diabetes, and tuberculosis. The new hope for most cancers remedy is that the medicine developed based mostly on FAS inhibitor could have higher properties with few negative effects, Prof. Sabu identified.

You have reached your restrict without spending a dime articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly model of articles from the day’s newspaper in a single easy-to-read checklist.

Unlimited Access

Enjoy studying as many articles as you would like with none limitations.

Personalised suggestions

A choose checklist of articles that match your pursuits and tastes.

Faster pages

Move easily between articles as our pages load immediately.


A one-stop-shop for seeing the most recent updates, and managing your preferences.


We transient you on the most recent and most necessary developments, 3 times a day.

Support Quality Journalism.

*Our Digital Subscription plans don’t at present embrace the e-paper, crossword and print.

Source hyperlink

Comment here